Angiomyolipoma of the Kidney Causes and Risk Factors

Angiomyolipoma of the kidney is a non-cancerous (benign) growth made of fat, smooth muscle, and blood vessels that usually forms in the kidneys. Most cases occur randomly without a clear cause, but some are linked to genetic conditions like tuberous sclerosis complex. These growths often cause no symptoms unless they become large or bleed.

What is Angiomyolipoma of the Kidney Causes and Risk Factors?

An angiomyolipoma (AML) of the kidney is a non-cancerous (benign) tumor that develops in the kidney. It is unique because it contains three types of tissue: fat, smooth muscle, and blood vessels. While it is a tumor, it is not cancer and typically does not spread to other parts of the body.

Angiomyolipomas are among the most common benign tumors of the kidney. They are often discovered by chance when imaging tests, such as an ultrasound or CT scan, are performed for other health reasons. Most people with an AML have only one, and it usually affects only one kidney. These growths vary widely in size, from very small to quite large. Small AMLs often cause no problems and may not require treatment. Larger AMLs, however, can sometimes lead to symptoms or complications, particularly if the blood vessels within them rupture and cause bleeding. It is important to understand that an angiomyolipoma is distinct from cancerous kidney tumors. Its benign nature means it does not behave like cancer, offering a generally favorable outlook for most individuals who have one. Regular monitoring is often recommended to track its size and characteristics over time.

Symptoms

Many angiomyolipomas, especially smaller ones, do not cause any noticeable symptoms and are often discovered incidentally. However, if an AML grows large or bleeds, it can lead to symptoms such as pain in the side or back, blood in the urine, or a noticeable lump in the abdomen.

When symptoms do occur, they are usually related to the size of the tumor or complications like bleeding. One common symptom is flank pain, which is discomfort or pain in the side or back, typically between the ribs and the hip. This pain can range from mild to severe, depending on the situation. Another potential symptom is blood in the urine (hematuria), which can make urine appear pink, red, or cola-colored. This happens if the blood vessels within the AML rupture. In some cases, a person might feel a lump or mass in their abdomen, particularly if the AML is large enough to be felt through the skin. Less commonly, if there is significant internal bleeding from a ruptured AML, a person might experience more severe symptoms. These can include a sudden drop in blood pressure (hypotension), a rapid heart rate, dizziness, or even fainting. Chronic, slow bleeding can also lead to anemia, causing fatigue and weakness.

Causes & risk factors

Most angiomyolipomas occur randomly without a clear cause and are called sporadic AMLs. However, a significant number are associated with specific genetic conditions, primarily tuberous sclerosis complex (TSC) and, less commonly, lymphangioleiomyomatosis (LAM).

The majority of kidney angiomyolipomas are sporadic, meaning they develop without any known genetic link or family history. These sporadic AMLs are more common in middle-aged women. The exact reason why these tumors form is not fully understood, but it is believed to involve random genetic changes in kidney cells that lead to uncontrolled growth of fat, muscle, and blood vessel tissues. In contrast, a substantial portion of AMLs are linked to a genetic disorder called tuberous sclerosis complex (TSC). This condition causes benign tumors to grow in various organs, including the brain, skin, heart, lungs, and kidneys. About 80% of individuals with TSC develop kidney AMLs, which are often multiple, grow in both kidneys, and tend to be larger and more prone to complications like bleeding. Another rare genetic condition, lymphangioleiomyomatosis (LAM), primarily affects the lungs but can also be associated with the development of kidney AMLs. While the causes differ, both sporadic and genetic forms of AML involve abnormal cell growth. It is important to note that AMLs are not contagious and are not caused by lifestyle factors like diet or exercise.

How it's diagnosed

Angiomyolipomas are frequently diagnosed by chance during imaging tests performed for other health concerns, as many do not cause symptoms. Doctors use imaging techniques like ultrasound, CT scans, or MRI to identify the characteristic fat content within the kidney growth, which helps confirm the diagnosis.

Because many AMLs are symptom-free, they are often discovered incidentally when a person undergoes imaging for unrelated conditions, such as abdominal pain or a routine check-up. Once a suspicious mass is found, further imaging is usually performed to confirm its nature. **Computed tomography (CT) scans** are particularly effective in diagnosing AMLs. They use X-rays and computer processing to create detailed cross-sectional images of the kidneys. The presence of fat within the kidney lesion is a key feature that helps distinguish an AML from other types of kidney tumors, including cancerous ones. **Magnetic resonance imaging (MRI)** can also be used, providing detailed images without radiation. Like CT scans, MRI can clearly show the fat content of an AML. **Ultrasound** is another common initial imaging tool, using sound waves to create images of the kidneys. While it can detect a mass, CT or MRI scans are often needed to confirm it is an AML due to their ability to identify fat. In most cases, a kidney biopsy (taking a tissue sample) is not necessary because the imaging characteristics of an AML are usually very distinct.

Treatment options

Treatment for an angiomyolipoma depends on its size, whether it causes symptoms, and its risk of bleeding. Small, symptom-free AMLs are often monitored with regular imaging. Larger or symptomatic AMLs may require procedures like embolization to block blood flow or surgery to remove the growth.

For small angiomyolipomas (typically less than 4 centimeters in diameter) that are not causing any symptoms, doctors often recommend a strategy called **watchful waiting** or observation. This involves regular follow-up appointments and imaging tests, such as ultrasound or CT scans, to monitor the AML's size and characteristics over time. The goal is to ensure it remains stable and does not grow or cause problems. If an AML is large (often greater than 4 cm), causes symptoms, or has a high risk of bleeding, more active treatment may be considered. One common procedure is **embolization**. During embolization, a doctor inserts a thin tube (catheter) into an artery and guides it to the blood vessels supplying the AML. A substance is then injected to block these vessels, cutting off the tumor's blood supply and causing it to shrink. **Surgery** may be recommended for very large AMLs, those that have ruptured and are bleeding severely, or those that cannot be treated with embolization. The preferred surgical approach is often a **partial nephrectomy**, where only the tumor and a small amount of surrounding kidney tissue are removed, preserving most of the kidney. In rare cases, if the AML is very large or has caused extensive damage, a **nephrectomy** (removal of the entire kidney) might be necessary. For AMLs associated with tuberous sclerosis complex, certain medications called mTOR inhibitors can help shrink the tumors and prevent new ones from forming.

Recovery & outlook

The outlook for individuals with kidney angiomyolipomas is generally very good, as these growths are non-cancerous and usually do not affect kidney function or life expectancy. Most people with small, stable AMLs live without complications, often requiring only regular monitoring.

Since angiomyolipomas are benign, they do not spread like cancer, and the vast majority of people who have them will not experience life-threatening complications. For those with small, asymptomatic AMLs, the primary approach is often observation, and many individuals will never require active treatment. Regular follow-up imaging helps ensure the tumor remains stable. Even when treatment is necessary, such as embolization or partial nephrectomy, the recovery is typically favorable. These procedures are generally effective in managing symptoms, preventing bleeding, or removing the growth while preserving kidney function as much as possible. After treatment, patients usually undergo a period of recovery, with specific instructions from their doctor regarding activity levels and follow-up care. Long-term monitoring is important, especially for individuals with genetic conditions like tuberous sclerosis complex, as they may develop new AMLs or experience growth of existing ones. Overall, with appropriate management and follow-up, most people with kidney angiomyolipomas can expect to maintain good health and kidney function.

When to see a doctor

You should see a doctor if you experience new or worsening symptoms related to your kidney, such as persistent pain in your side or back, blood in your urine, or a noticeable lump in your abdomen. Seek immediate medical attention for severe, sudden pain, dizziness, or signs of heavy internal bleeding.

It is important to contact your doctor if you notice any changes in your health that could be related to an angiomyolipoma. This includes any new or increasing pain in your flank (side or back), especially if it is persistent or severe. Any instance of blood in your urine, even if it appears only once or is a small amount, warrants medical evaluation. Other symptoms that should prompt a doctor's visit include feeling a new lump or swelling in your abdomen, or experiencing unexplained fatigue or weakness, which could be a sign of anemia from slow blood loss. Your doctor can assess your symptoms and determine if further investigation or treatment is needed. Seek immediate emergency medical care if you experience sudden, severe pain in your side or abdomen, accompanied by symptoms like dizziness, lightheadedness, fainting, or a rapid heart rate. These could be signs of significant internal bleeding from a ruptured angiomyolipoma, which is a medical emergency requiring urgent attention.

Frequently asked questions

Can kidney angiomyolipomas turn into cancer?

No, angiomyolipomas are benign (non-cancerous) tumors and do not turn into cancer. They are made of fat, smooth muscle, and blood vessels, and their cellular structure is distinct from malignant kidney tumors. While they can grow and cause symptoms, they do not spread to other parts of the body like cancer.

How fast do kidney angiomyolipomas grow?

The growth rate of kidney angiomyolipomas varies greatly. Many remain stable in size for years, while others may grow slowly over time. AMLs associated with genetic conditions like tuberous sclerosis complex tend to grow faster and are more likely to be multiple and larger than sporadic AMLs. Regular monitoring helps track their growth.

Is surgery always necessary for a kidney angiomyolipoma?

No, surgery is not always necessary. Small, symptom-free angiomyolipomas are often managed with watchful waiting and regular imaging to monitor their size. Surgery or other procedures like embolization are typically reserved for larger AMLs (often over 4 cm), those causing symptoms, or those at high risk of bleeding.

What are the chances of an angiomyolipoma bleeding?

The risk of an angiomyolipoma bleeding increases with its size. Smaller AMLs (under 4 cm) have a low risk of bleeding. Larger AMLs, especially those over 4 cm, have a higher risk of rupture and bleeding, which can sometimes be severe. This risk is a key factor in deciding whether to treat an AML.

Do I need to change my diet if I have an angiomyolipoma?

There is no specific diet recommended or required for people with angiomyolipomas. These growths are not caused by dietary factors. However, maintaining a generally healthy diet and lifestyle is always beneficial for overall health and kidney function, especially if you have other health conditions.

Can angiomyolipomas affect kidney function?

In most cases, small angiomyolipomas do not affect kidney function. Even larger AMLs often do not impair kidney function unless they are very large, cause significant bleeding, or require extensive surgical removal of kidney tissue. Partial nephrectomy, which removes only the tumor, aims to preserve as much kidney function as possible.

Sources

• MedlinePlus — Angiomyolipoma of the Kidney Causes and Risk Factors
• Mayo Clinic — Angiomyolipoma of the Kidney Causes and Risk Factors
• Cochrane Library — Angiomyolipoma of the Kidney Causes and Risk Factors